Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2005 (Vol. 25, No. 4)

Biomedical Acronym Database

URL:invention.swmed.edu/argh/
  • massive dataset
  • Not an ideal dictionary
If you have any doubts that we scientists speak a language all our own, you’ll lose them after taking a look at the Biomedical Acronym Database. The note on the opening page is eye-popping—the site contains 206,000 of the estimated 224,000 unique acronyms in Medline. Gulp! That’s an entire language embedded in the one we speak. How could anyone reasonably expect to stay on top of such lingo? Fortunately, the Biomedical Acronym Database provides a path to enlightenment, with a simple search engine access. This is not your usual dictionary, however, as it is generated by an automated scanning of Medline and, consequently, the “definitions” frequently do not look like they are out of a dictionary. Perhaps more importantly, the database provides Medline links where users can go for additional info.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »